China Yida Holding Co (NASDAQ:CNYD) skyrockets on Optimistic Future Outlook. Wall Street analyst are optimistic on what revenue, sales, and business outlook China Yida Holding, Co. will produce, especially since the Company reported a hardy 68.5% rise in tourism income for the prior Q4 of 2012. China Yida Holding Co (NASDAQ:CNYD) stock opened at $3.50 in last trading session, and closed at $7.24, trading in the range of $3.35 – $9.47. The stock showed a positive/negative weekly performance of 124.84%.
Patients who received Intercept Pharmaceuticals Inc (NASDAQ:ICPT)’s experimental liver-disease drug in a clinical trial experienced more abnormal cholesterol levels than those taking a placebo, in addition to improvements in their liver health, according to the National Institutes of Health. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares closed at $445.83 on last trade day, by gaining 61.61%. Stock 52 week range is $30.38 – $497.00. Company’s market capitalization is $8.62 billion.
Zacks, current mean recommendation for Conatus Pharmaceuticals Inc (NASDAQ:CNAT) is in the “strong buy range”. Conatus Pharmaceuticals Inc (NASDAQ:CNAT) stock surged 45.41% and finished the last session at $14.25. The EPS of the stock remained -4.92. Company’s market capitalization is $222.58 billion.
Barclays hoisted their target price on shares of PharMerica Corporation (NYSE:PMC) from $14.00 to $16.00 in a research note issued on Wednesday, Stock Ratings Network.com reports. The firm currently has an “underweight” rating on the stock. Barclays’ target price points to a potential downside of 21.53% from the stock’s previous close. PharMerica Corporation (NYSE:PMC) stock opened at $20.56 in last trading session and closed at $25.91. The 52 week range of the stock is $11.84 – $25.97 and the day range was $20.40 – $25.97.